Research Article

Clinical and Pathological Variation of Charcot-Marie-Tooth 1A in a Large Chinese Cohort

Table 1

Clinical features and nerve conduction studies (NCS) of the patients analyzed in this study.

Patient numberGenderAge of evaluation (years)Age of onset (years)Disease duration (years)Strength of musclePes cavusSensory lossAreflexia Muscle atrophyMedian nerve MCV (m/s)Median nerve CMAP (mV)
Upper limbLower limbHandCalf

1F137655YYYYN21.03.3
2M880.544NNYNN
3M2726152YYYNN
4M37112642YNYNN11.01.9
5M3224843NYYYY51.04.6
6M3932744NYYYY
7F4839942NNYYY
8F45252054NYYYY
9F95354YYYNN14.05
10F3836232YYNYN14.0
11F28131544YYNYN00
12F3633344YNYYN20.01.3
13M81744YNYNN30.05
14M33231033NNYYY
15M96355YYYYY
16M5955454NYYNN22.02.4
17M2121841YYYNY22.17.9
18M3130155YNYNN
19M4239344YYYYY24.0
20M3531454YYYYY
21F3632453NNYNN16.02.4
22F35251041NYYYY15.91
23M3128355NYYNN00
24F81.5654NNYNN

Note. M: male; F: female; Y: yes; N: no; MCV: motor conduction velocity; CMAP: compound muscle action potential amplitude. Black bar means material defect.